Fatih Uckun, M.D., Ph.D., is a notable researcher in the fields of molecular biology, nanotechnology, and biotherapy. He has published more than 400 peer-reviewed reports and participates actively in the American Society of Hematology, the American Society of Clinical Oncology, and the American Association for Cancer Research. Currently, Dr. Fatih Uckun serves as director of the Nanomedicine Research and Development program at Children’s Hospital Los Angeles (CHLA).

1. By Fatih Uckun

2. 
Fatih Uckun, M.D., Ph.D., is a notable researcher
in the fields of molecular
biology, nanotechnology, and biotherapy. He has
published more than 400 peer-reviewed reports
and participates actively in the American Society
of Hematology, the American Society of Clinical
Oncology, and the American Association for
Cancer Research. Currently, Dr. Fatih Uckun
serves as director of the Nanomedicine Research
and Development program at Children’s Hospital
Los Angeles (CHLA).

3. 
A leading national children’s hospital, CHLA
possesses a global reputation for pediatric and
adolescent care. U.S. News & World Report ranked all
10 of the hospital’s pediatric specialties for two
consecutive years. In 2012, the leading newspaper
ranked CHLA as the fifth top pediatric hospital in the
nation.
The institution also maintains a reputation as a
leading pediatric teaching hospital and has trained
doctors at the University of Southern California’s Keck
School of Medicine since 1932. It continues to
expand with the recent completion of the 317-bed
Marion and John E. Anderson Pavilion, a $600 million
expansion project.